Daobin Zhou

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Yue Shi, Mei Dong, Xiaoting Hong et al. · Annals of Oncology · 2015 · 384 citations

Lymphoid Neoplasia, Medicine, Immunology +7

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Xiaohui Zhang, Jing Chen, Mingzhe Han et al. · Journal of Hematology & Oncology · 2021 · 290 citations · Full text

Clinical characteristics and long-term outcome of patients with POEMS syndrome in China

Daobin Zhou, Zhen Huang, Jiao Li et al. · Annals of Hematology · 2011 · 160 citations

Poems Syndrome, Clinical Characteristics, Long-term Outcome +1

Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome

Wei Zhang, Jiao Li, Minghui Duan et al. · Blood · 2011 · 134 citations · Full text

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 128 citations · Full text